puzzle picture
377: CASP9 Puzzle 41
Status: Closed

Summary

Name: 377: CASP9 Puzzle 41
Status: Closed
Created: 10/27/2010
Points: 100
Expired: 11/03/2010 - 07:00
Difficulty: Intermediate
Description: We are giving you a server-only CASP9 target whose structure has not been released yet. You have 9 server predictions as starting models, so anytime you reset you will randomly start with one of the 9 models. You can also access each model individually by using the Alignment Tool, as all 9 server models are in your template reserve as well as an extended chain. Note that although the sequences for each model are identical in the Alignment Tool, threading will result in very different starting structures.
Categories:

Top Groups

RankGroupScorePoints
16Another Hour Another Point10,3181
17BOINC@Denmark10,2971
18Skeptics Guide to the Universe10,1251
19Ninjas10,0901
20Wiscofolders10,0311

Top Evolvers

Top Soloists



Need this puzzle? Log in to download.  

Comments

Ignacio's picture
User offline. Last seen 1 year 12 weeks ago. Offline
Joined: 05/10/2008
Groups: Go Science
Problem alignment no.10?

It looks like this alignment leads to an unstructured protein

beta_helix's picture
User offline. Last seen 9 hours 36 min ago. Offline
Joined: 05/09/2008
Groups: None
You are correct.

"all 9 server models are in your template reserve as well as an extended chain."

The 10th alignment, called "extend", is simply an extended chain with the same sequence.

It was added there by request, feel free to ignore it.

User login
Download links:
  Windows    OSX    Linux  
Windows
(7/8/10)
OSX
(10.12 or later)
Linux
(64-bit)

Are you new to Foldit? Click here.

Are you a student? Click here.

Are you an educator? Click here.
Social Media


Search
Only search fold.it
Other Games: Mozak
Recommend Foldit
Topics
Top New Users
Sitemap

Developed by: UW Center for Game Science, UW Institute for Protein Design, Northeastern University, Vanderbilt University Meiler Lab, UC Davis
Supported by: DARPA, NSF, NIH, HHMI, Amazon, Microsoft, Adobe, Boehringer Ingelheim, RosettaCommons